We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sapiens International (SPNS - Free Report) recently unveiled an artificial intelligence (AI)-based Decision Automated Logic Extraction (ALE) solution.
This latest solution helps in the successful digital transformation of insurance providers by extracting and transforming business logic from legacy systems without disruption, reduced performance or loss of functionality.
Decision ALE helps in the extraction and transformation of business data from legacy systems to decision models for ongoing management in Sapiens Decision Manager. It also helps in lowering operational costs for insurance providers.
Sapiens Riding on Portfolio Strength & Expanding Partner Base
Sapiens is gaining traction with higher-tier carriers, driven by its portfolio strength. Moreover, its expanding partner base has been a key catalyst.
Recently, AEGIS selected Sapiens’ ReinsurancePro to enhance its internal controls processes, automated calculations and reporting. It will replace AEGIS’ complex custom applications and spreadsheets.
Sapiens International Corporation N.V. Price and Consensus
Moreover, the Sapiens Intelligence solution was deployed by Old Mutual Insure, South Africa's oldest insurance company. Sapiens’ IllustrationPro, ApplicationPro and DigitalSuite were selected by EquiTrust Life, a leading North American life and health insurance company.
Other notable wins in recent times include NYCM Insurance, Altshuler Shaham Investment House and Encova Insurance, among others.
Meanwhile, in August, Sapiens announced four new strategic partnerships — with Akur8, Shift, Soleadify and Imburse — to expand its footprint in the European market. These partnerships expanded Sapiens’ customers’ access to the widest range of innovative insuretech solutions in the region.
Sapiens also entered into an agreement with Intellagents, a no-code, hybrid cloud, independent insurance marketplace platform provider, to expand its P&C ecosystem and connect its agents and insurers to a new digital marketplace with best-in-class insuretech solutions, data sources, AI providers and more.
What Awaits Sapiens Shares in the Rest of 2022?
Sapiens’ strong portfolio and expanding partner base are expected to boost its top-line growth. For 2022, Sapiens now expects revenues between $480 million and $485 million, indicating growth of 9.5% at a constant currency basis over 2021.
The current guidance is lower than the previous revenue expectation of $495-$500 million due to unfavorable forex as well as the delayed completion of a European deal.
The Zacks Consensus Estimate for 2022 revenues is currently pegged at $483.45 million, indicating 4.86% growth from the figure reported in 2021. Moreover, the consensus mark for 2022 earnings has been steady over the past 30 days at $1.17 per share.
Sapiens has underperformed the Zacks Computer and Technology sector year to date. The company’s shares have declined 41% compared with the sector’s decline of 31.7% year to date.
Absolute shares have gained 16.4% in the year-to-date period. The Zacks Consensus Estimate for ABST’s fiscal 2023 earnings has moved 487.5% higher over the past 30 days to 47 cents per share.
Paylocity shares have gained 7.5% in the year-to-date period. The Zacks Consensus Estimate for PCTY’s fiscal 2023 earnings has been steady over the past 30 days at $3.58 per share.
Synchronoss shares have lost 49.2% in the year-to-date period. The consensus mark for SNCR’s 2022 earnings has been steady at 16 cents per share over the past 30 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sapiens' (SPNS) Latest AI-Based Solution Strengthens Portfolio
Sapiens International (SPNS - Free Report) recently unveiled an artificial intelligence (AI)-based Decision Automated Logic Extraction (ALE) solution.
This latest solution helps in the successful digital transformation of insurance providers by extracting and transforming business logic from legacy systems without disruption, reduced performance or loss of functionality.
Decision ALE helps in the extraction and transformation of business data from legacy systems to decision models for ongoing management in Sapiens Decision Manager. It also helps in lowering operational costs for insurance providers.
Sapiens Riding on Portfolio Strength & Expanding Partner Base
Sapiens is gaining traction with higher-tier carriers, driven by its portfolio strength. Moreover, its expanding partner base has been a key catalyst.
Recently, AEGIS selected Sapiens’ ReinsurancePro to enhance its internal controls processes, automated calculations and reporting. It will replace AEGIS’ complex custom applications and spreadsheets.
Sapiens International Corporation N.V. Price and Consensus
Sapiens International Corporation N.V. price-consensus-chart | Sapiens International Corporation N.V. Quote
Moreover, the Sapiens Intelligence solution was deployed by Old Mutual Insure, South Africa's oldest insurance company. Sapiens’ IllustrationPro, ApplicationPro and DigitalSuite were selected by EquiTrust Life, a leading North American life and health insurance company.
Other notable wins in recent times include NYCM Insurance, Altshuler Shaham Investment House and Encova Insurance, among others.
Meanwhile, in August, Sapiens announced four new strategic partnerships — with Akur8, Shift, Soleadify and Imburse — to expand its footprint in the European market. These partnerships expanded Sapiens’ customers’ access to the widest range of innovative insuretech solutions in the region.
Sapiens also entered into an agreement with Intellagents, a no-code, hybrid cloud, independent insurance marketplace platform provider, to expand its P&C ecosystem and connect its agents and insurers to a new digital marketplace with best-in-class insuretech solutions, data sources, AI providers and more.
What Awaits Sapiens Shares in the Rest of 2022?
Sapiens’ strong portfolio and expanding partner base are expected to boost its top-line growth. For 2022, Sapiens now expects revenues between $480 million and $485 million, indicating growth of 9.5% at a constant currency basis over 2021.
The current guidance is lower than the previous revenue expectation of $495-$500 million due to unfavorable forex as well as the delayed completion of a European deal.
The Zacks Consensus Estimate for 2022 revenues is currently pegged at $483.45 million, indicating 4.86% growth from the figure reported in 2021. Moreover, the consensus mark for 2022 earnings has been steady over the past 30 days at $1.17 per share.
Sapiens has underperformed the Zacks Computer and Technology sector year to date. The company’s shares have declined 41% compared with the sector’s decline of 31.7% year to date.
Zacks Rank & Stocks to Consider
Sapiens currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the same industry are Absolute Software , Paylocity (PCTY - Free Report) and Synchronoss (SNCR - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Absolute shares have gained 16.4% in the year-to-date period. The Zacks Consensus Estimate for ABST’s fiscal 2023 earnings has moved 487.5% higher over the past 30 days to 47 cents per share.
Paylocity shares have gained 7.5% in the year-to-date period. The Zacks Consensus Estimate for PCTY’s fiscal 2023 earnings has been steady over the past 30 days at $3.58 per share.
Synchronoss shares have lost 49.2% in the year-to-date period. The consensus mark for SNCR’s 2022 earnings has been steady at 16 cents per share over the past 30 days.